Skip to content

Virtual Reality Training for Heart Rate Variability and Recovery Heart Rate

Effects of Virtual Reality Training on Heart Rate Variability and Recovery Heart Rate in Sedentary Individuals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06708364
Enrollment
46
Registered
2024-11-27
Start date
2024-11-20
Completion date
2025-05-15
Last updated
2025-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedentary Behavior

Keywords

Heart rate variability, Recovery Heart rate, Virtual Reality Training, Sedentary life style

Brief summary

To determine effects of VR training on Heart Rate Variability (HRV), Recovery Heart rate (RHR), Rate Pressure Product (RPP) and Rate of Perceived Exertion (RPE) in sedentary Individuals. Sedentary behavior is a significant public health concern associated with various chronic diseases and reduced quality of life. By elucidating the potential of virtual reality training as an innovative approach to promote physical activity and improve cardiovascular health, this research contributes to addressing the growing burden of sedentary lifestyle-related health conditions.

Detailed description

Virtual reality (VR) training in cardiopulmonary rehabilitation (CR) offers an innovative approach to traditional exercise programs by incorporating enjoyable activities. Utilizing VR enhances cardiopulmonary endurance training and promotes the beneficial effects of CR by engaging patients in fun and challenging activities. This approach aims to increase motivation and adherence to CR over an extended period, resulting in improved mental and physical outcomes compared to conventional CR programs

Interventions

OTHERVirtual Reality Training

Virtual reality training (X-BOX). Table tennis * Frequency: 3 day per week * Intensity: Mild to moderate as per Game. Exer-game ( River Rush) * Time: total 30 minute of training with 5 min warm and 5 min cool down. * Type: aerobic exercise

* Frequency: 3 days per week. * Intensity: 40-60% of HRR * Time: total 30 minutes with 5 min warm up and 5 min cool down * Type: aerobic exercise

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Sedentary Individuals (IPAQ-short version) \< 3.3 METS daily * Daily sitting time≤7 hours

Exclusion criteria

* Decline Consent * Known cases of systemic or Cardiovascular Diseases. * Obese (Asian BMI) \> 29.9 * Any contra-indication to exercise/ Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Heart Rate Variability (HRV)2 weeks, 4 weeks, 6 weeksFrom baseline till 2nd, 4th, and 6th weeks measured through wireless ECG device which measures inter-beat (RR) intervals while doing physical activities. In adults , average HRV is 42 milliseconds.
Recovery Heart Rate2 weeks, 4 weeks, 6 weeksFrom baseline till 2nd, 4th, and 6th weeks measured through pulse oximeter. One-minute HRR for the average person is between 15 to 25 bpm, with a higher number indicating a quicker recovery and a potentially healthier heart.
Rate Pressure Product2 weeks, 4 weeks, 6 weeksChanges from baseline to 2 weeks, 4 weeks and 6 weeks after the intervention, measured through product of heart rate and systolic blood pressure, is a very reliable indicator of myocardial oxygen demand. An RPP above 20,000 mmHg per minute is considered healthy, whereas anything below 16,000 mmHg is considered insufficient.
Rating of Perceived Exertion (RPE)2 weeks, 4 weeks, 6 weeksChanges from baseline to 2 weeks, 4 weeks and 6 weeks after the intervention, measured through Borg RPE scale for measuring an individual's effort and exertion, breathlessness and fatigue during physical work. The RPE scale ranges from 6 to 20, each gradually related to the respondent's perceived exertion level.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026